The US based Purdue Pharma products LP and its partner Napp Pharmaceutical Group Ltd have filed a patent infringement petition against Sun Pharmaceuticals and its US arms following a para IV certification filed by the latter to manufacture and market generic version of the former's pain killer - Ryzolt - tramadol hydrochloride extended-release drug.
The details can be read here.
No comments:
Post a Comment